Population pharmacokinetics of polymyxin B in critically ill patients with multi–drug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections
Puteri Juanita Zamri, Saskia A. Wölky, Maria P. Hernandez-Mitre, Xin Liu et autres
• This is the first study to characterise the population pharmacokinetics of polymyxin B in a hospitalised patient population in Malaysia and importantly, only the third reported study from Southeast Asia. • In this study cohort, 12 out of 29 patients demonstrated …
au, my (code pays fourni par la source)